TW304878B - - Google Patents

Download PDF

Info

Publication number
TW304878B
TW304878B TW083108317A TW83108317A TW304878B TW 304878 B TW304878 B TW 304878B TW 083108317 A TW083108317 A TW 083108317A TW 83108317 A TW83108317 A TW 83108317A TW 304878 B TW304878 B TW 304878B
Authority
TW
Taiwan
Prior art keywords
group
atom
compound
item
hydrogen atom
Prior art date
Application number
TW083108317A
Other languages
English (en)
Chinese (zh)
Original Assignee
Takeda Pharm Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharm Industry Co Ltd filed Critical Takeda Pharm Industry Co Ltd
Application granted granted Critical
Publication of TW304878B publication Critical patent/TW304878B/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • A61K31/5025Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW083108317A 1993-09-21 1994-09-09 TW304878B (h)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23476493 1993-09-21

Publications (1)

Publication Number Publication Date
TW304878B true TW304878B (h) 1997-05-11

Family

ID=16975996

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083108317A TW304878B (h) 1993-09-21 1994-09-09

Country Status (10)

Country Link
US (2) US5922712A (h)
EP (2) EP0648491A3 (h)
KR (1) KR100280240B1 (h)
CN (1) CN1109885A (h)
AU (1) AU686210B2 (h)
CA (1) CA2132489A1 (h)
FI (1) FI944354A0 (h)
NO (1) NO307547B1 (h)
NZ (1) NZ264479A (h)
TW (1) TW304878B (h)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0781283B1 (en) * 1994-09-16 2001-06-06 Takeda Chemical Industries, Ltd. Triazolopyridazines process and intermediates for their preparation and their use as medicaments
KR100389192B1 (ko) 1997-04-25 2003-06-27 다케다 야쿠힌 고교 가부시키가이샤 축합 피리다진 유도체, 그것의 제조 방법 및 용도
WO1999044611A1 (en) * 1998-03-04 1999-09-10 Takeda Chemical Industries, Ltd. Triazolo-pyridazine derivatives for the treatment of chronic obstructive pulmonary diseases
WO2000020417A1 (fr) 1998-10-06 2000-04-13 Takeda Chemical Industries, Ltd. Composes de pyridazine condenses, leur procede de preparation et leur utilisation
CA2348022A1 (en) 1998-10-21 2000-04-27 Takeda Chemical Industries, Ltd. Condensed pyridazine derivatives, their production and use
WO2001021177A1 (fr) * 1999-09-20 2001-03-29 Takeda Chemical Industries, Ltd. Inhibiteurs d'expression de chemokine/cytokine
CN1413112A (zh) * 1999-11-11 2003-04-23 武田药品工业株式会社 含有稠合哒嗪衍生物的滴鼻剂
AU2006331912B2 (en) 2005-12-21 2012-08-30 Janssen Pharmaceutica, N.V. Triazolopyridazines as tyrosine kinase modulators

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3446812A1 (de) * 1984-12-21 1986-06-26 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazoderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel
GB8826205D0 (en) * 1988-11-09 1988-12-14 Wellcome Found Heterocyclic compounds
PH27291A (en) * 1989-01-31 1993-05-04 Takeda Chemical Industries Ltd Imidazolpyrimidazines their production and use
EP0440119A1 (en) * 1990-01-31 1991-08-07 Takeda Chemical Industries, Ltd. Imidazopyridazine compounds, their production and use
US5011835A (en) * 1990-02-07 1991-04-30 Merrell Dow Pharmaceuticals Inc. Substituted triazolopyridazines, pharmaceutical compositions and use
DE69106902T2 (de) * 1990-03-01 1995-07-06 Takeda Chemical Industries Ltd Imidazopyridazine, ihre Herstellung und Verwendung.
DE4007373A1 (de) * 1990-03-08 1991-09-12 Precitronic Pyrotechnische vorrichtung
WO1992010491A1 (en) * 1990-12-14 1992-06-25 Merrell Dow Pharmaceuticals Inc. Antiallergic compounds
TW211013B (h) * 1991-12-27 1993-08-11 Takeda Pharm Industry Co Ltd
LT3200B (en) * 1992-03-18 1995-03-27 Takeda Chemical Industries Ltd Triazolopyridazine methodfor production thereof and use
EP0562440B1 (en) * 1992-03-18 1998-12-23 Takeda Chemical Industries, Ltd. Imidazopyridazines as antiasthmatics

Also Published As

Publication number Publication date
AU7292694A (en) 1995-04-06
EP0648491A3 (en) 1995-07-19
EP0865790A3 (en) 1999-03-10
EP0648491A2 (en) 1995-04-19
NZ264479A (en) 1999-05-28
NO943494L (no) 1995-03-22
FI944354A0 (fi) 1994-09-20
NO943494D0 (no) 1994-09-20
KR950007851A (ko) 1995-04-15
AU686210B2 (en) 1998-02-05
EP0865790A2 (en) 1998-09-23
NO307547B1 (no) 2000-04-25
US5945419A (en) 1999-08-31
KR100280240B1 (ko) 2001-02-01
CN1109885A (zh) 1995-10-11
CA2132489A1 (en) 1995-03-22
US5922712A (en) 1999-07-13

Similar Documents

Publication Publication Date Title
RU2202552C2 (ru) Производные 1,2,4-триазоло[4,3-b]пиридо[3,2-d]пиридазина, способ их получения, фармацевтическая композиция и способ ингибирования фосфодиэстеразы-4
TWI261591B (en) Derivatives of 6,7-dihydro-5H-imidazo[1,2-a]imidazole and pharmaceutical compositions comprising the same
US20240400567A1 (en) Aurora kinase inhibitors for inhibiting mitotic progression
EP2074115B1 (en) N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors
JP6795585B2 (ja) Axlインヒビタおよび免疫チェックポイントモジュレータまたは腫瘍溶解性ウィルスによる併用療法
US20150005319A1 (en) Macrocyclic compounds for modulating il-17
TW304878B (h)
US20110201587A1 (en) Hsp90 inhibitors and methods of use
CN115916775B (zh) Atr抑制剂及其用途
JP5681226B2 (ja) メチルフェニデート誘導体を含む治療剤
JP2018508553A (ja) 置換三環式ヘテロ環式化合物
EA014714B1 (ru) Арилвинилазациклоалкановое соединение, фармацевтическая композиция на его основе и способы его применения
CN101485661A (zh) 一种青藤碱衍生物通过拮抗TNF-α信号通路治疗自身免疫病
JP7677912B2 (ja) ジアリールアミド化合物及びそれらの用途
CN110003171B (zh) 治疗类风湿性关节炎的小分子可逆性btk抑制剂
CN112189009B (zh) 作为tcr-nck相互作用的抑制剂的色烯衍生物
CN105873924B (zh) 一种1-(3-氨基丙基)取代环状胺类化合物、其制备方法、药物组合物及用途
RU2369600C1 (ru) ЗАМЕЩЕННЫЕ 4-СУЛЬФОНИЛ-ПИРАЗОЛЫ И 3-СУЛЬФОНИЛ-ПИРАЗОЛО[1,5-a]ПИРИМИДИНЫ - АНТАГОНИСТЫ СЕРОТОНИНОВЫХ5-HT6 РЕЦЕПТОРОВ, АКТИВНЫЙ КОМПОНЕНТ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ЛЕКАРСТВЕННОЕ СРЕДСТВО И СПОСОБЫ ИХ ПОЛУЧЕНИЯ
CN113666877B (zh) 含烷氧基及酰胺基的tyk2抑制剂化合物
US20230132808A1 (en) Wnt/cbp/catenin signaling pathway inhibitors and uses thereof
TW200908958A (en) Tricyclic compounds for the treatment of inflammatory disorders
CN115850176B (zh) 一种青藤碱衍生物及其制备方法、应用
JPH03115267A (ja) プロピオフエノン誘導体、その製造方法、それを含む中枢性筋弛緩剤および抗痙攣剤
CN1997364A (zh) 显示cb1-拮抗活性的化合物的新医学用途和包含所述化合物的联合治疗
CN101137379B (zh) 用于治疗医学病症的cxcr4拮抗剂